|
|
|
|
|
|
|
|
|
|
|
|
|
|
mAb to 3-ethyl-adenine (EM 6-47) |
|
|
Product Data |
|
Graphics |
|
Product Flyer |
|
References |
|
|
|
|
|
|
|
|
|
|
|
|
|
Request info |
|
|
|
|
|
Product Name |
mAb to 3-ethyl-adenine (EM 6-47) |
|
|
Synonyms |
EM 6-47 monoclonal antibody |
|
|
Catalog No |
SQM013.1 |
|
|
Size |
50 µg |
|
|
Price |
375,00 EUR |
|
|
Category |
Antibodies and Conjugates |
|
|
Description |
monoclonal antibody, specific for 3-ethyl-adenine |
|
|
Background |
DNA-lesion specific monoclonal antibody |
|
|
Feature |
Detects a specific mutagenic DNA modification induced by several exogenous and endogenous carcinogens e.g. food, smoking, cancer therapeutics, environmental carcinogens, workplace carcinogens; Molecular epidemiology of carcinogen exposure; Pre- and intratherapeutic dosimetry of exposure to anticancer agents; Basic research of molecular mechanisms of carcinogenesis; Mutagenicity testing of substances |
|
|
Molecular Weight |
160 kDa |
|
|
Presentation |
lyophilized |
|
|
Reconstitution |
reconstitute with 0.5 ml of PBS, 0.05% sodium azide, 1% bovine serum albumine |
|
|
Stabilizer |
none |
|
|
Storage |
-20°C |
|
|
Applications |
Competitive Radioimmunoassay, ELISA |
|
|
Characteristics |
specifically reacts with 3-ethyl-adenine in human, rat |
|
|
Host |
mouse |
|
|
Isotype |
IgG1 |
|
|
Clonality |
monoclonal |
|
|
Clone |
EM 6-47 |
|
|
Immunogen |
3-ethyl-adenine-Thyroglubulin conjugate |
|
|
Specificity |
3-ethyl-adenine |
|
|
Cross Reactions |
see RIA specifity table (see graphics) |
|
|
Affinity Constant |
4.7 x 10 e9 (l/Mol) |
|
|
Purification |
Protein G affinity purification from cell culture supernatant |
|
|
Purity |
>95% |
|
|
Working Dilution |
test dependent |
|
|
Expiry |
1 year |
|
|
Considerations for Use |
Please store the vial at 4-8 deg. C. The product is stable for 1 year at 4-8 deg. C in its stock solution. Working dilutions should always be prepared freshly. For extended storage of the stock solution please add 50% glycerol and freeze the product. |
|
|
Keywords |
mutagenic DNA-modification; mAb, monoclonal antibody to modified DNA-base; mutagenicity testing, cacinogenesis, intratherapeutic dosimetry, molecular epidemiology; DNA-adduct; O-alkyl adduct detection in DNA |
|
|